Halozyme Therapeutics, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Halozyme Therapeutics, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Halozyme Therapeutics, Inc. stocks after a simple registration process. </div>

Q: How to buy Halozyme Therapeutics, Inc. shares in India?

<div> To buy Halozyme Therapeutics, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Halozyme Therapeutics, Inc. and you are done!</div> </div>

Q: What is the share price of Halozyme Therapeutics, Inc.?

<div>The share price of Halozyme Therapeutics, Inc. is USD 39.82 as on 2 May.</div>

Q: What is the Market Capitalization of Halozyme Therapeutics, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Halozyme Therapeutics, Inc. is USD 5.06B as on 2 May.</div>

Q: What is the PE ratio of Halozyme Therapeutics, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Halozyme Therapeutics, Inc. is 17.73 as on 2 May. </div>

Q: Is Halozyme Therapeutics, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Halozyme Therapeutics, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Halozyme Therapeutics, Inc. operate?

<div> Halozyme Therapeutics, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$39.82

+0.52

(2 May)

Loading Chart

Previous close

$39.82

Open

$39.82

Today’s high

$40.74

Today’s low

$38.88

52W low

$29.85

52W high

$45

25.06%

19.35%

17.73

EPS (TTM)

2.10

Shares O/S

127.05M

Market cap

5.06B

Insights

No insights found for this stock

Compare with other stock

About Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. The Company’s ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, its commercially validated solution is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids, with a focus on reducing treatment burden for patients.

It also develops, manufactures, and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED, partnered commercial products and ongoing product development programs with several pharmaceutical companies. It markets and sells Hylenex recombinant, which is a formulation of rHuPH20. It markets and sells its proprietary product XYOSTED for SC administration of testosterone replacement therapy (TRT) in adult males. .

FAQs

Can I buy Halozyme Therapeutics, Inc. shares in India?

How to buy Halozyme Therapeutics, Inc. shares in India?

What is the share price of Halozyme Therapeutics, Inc.?

What is the Market Capitalization of Halozyme Therapeutics, Inc.?

What is the PE ratio of Halozyme Therapeutics, Inc.?

Is Halozyme Therapeutics, Inc. a good stock to buy?

In which sector / industry does Halozyme Therapeutics, Inc. operate?